Neurometa Therapeutics
PrivateLast Round
Accelerator
May 21, 2025
Total Funding Raised
$2.46M
Company Overview
Neurometa Therapeutics is a biotechnology company developing a novel neurometabolic approach to treating neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurometa Therapeutics Comparables
Compare Neurometa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NRG Therapeutics | 81% | |
| T3D Therapeutics, Inc. | 77% | |
| Clene | 75% | |
Neurometa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 21, 2025 | ||||
| Grant | Dec 10, 2022 | ||||
| Seed | Sep 22, 2020 |
Key People
Founding team and executive leadership
Neurometa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of War | Grant |
| BioInnovation Institute | Seed |
| SmiLe Venture Hub | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2025
Grew 60% QoQ, from 10 to 16 employees.
- Oct 15, 2025
Grew 45% QoQ, from 11 to 16 employees.
Neurometa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurometa Therapeutics's valuation, stock price, and market status.